MiNK Therapeutics, Inc.
NASDAQ:INKT
0.729 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -22.458 | -27.991 | -30.213 | -16.239 | -23.802 |
| Depreciation & Amortization
| 0.205 | 0.122 | 0.078 | 0.055 | 0.037 |
| Deferred Income Tax
| -3,862.693 | 0 | -0.356 | 0 | 0 |
| Stock Based Compensation
| 3.86 | 3.027 | 1.745 | 0.088 | 0.22 |
| Change In Working Capital
| 2.897 | 8.767 | 3.736 | -0.325 | 4.115 |
| Accounts Receivables
| 0 | 0 | 0 | 1.802 | 3.433 |
| Inventory
| 0 | 0 | 0 | -1.802 | -3.433 |
| Accounts Payables
| -1.918 | 2.661 | -0.152 | 0.608 | 0.887 |
| Other Working Capital
| 4.815 | 6.106 | 3.888 | -0.933 | 3.229 |
| Other Non Cash Items
| 3,862.426 | -2.791 | 12.182 | 8.083 | 4.486 |
| Operating Cash Flow
| -15.763 | -18.867 | -12.827 | -8.338 | -14.944 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.074 | -0.25 | -0.249 | -0.095 | -0.426 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -73.561 | -250.046 | -248.983 | 0 | 0 |
| Investing Cash Flow
| -0.074 | -0.25 | -0.249 | -0.095 | -0.426 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | -9.459 | -11.105 | -11.436 |
| Common Stock Issued
| 0.07 | 293.523 | 39.797 | 0.001 | 0 |
| Common Stock Repurchased
| -0.478 | -0.157 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.478 | -293.521 | 18.919 | 22.211 | 22.872 |
| Financing Cash Flow
| -0.407 | -0.156 | 49.257 | 11.106 | 11.436 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| -0.025 | 0.019 | 0.017 | -0.281 | -0.122 |
| Net Change In Cash
| -16.268 | -19.253 | 36.198 | 2.392 | -4.057 |
| Cash At End Of Period
| 3.367 | 19.636 | 38.889 | 2.691 | 0.299 |